They further suggest that the STAT1/STAT3 ratio is dynamically regulated in individual human breast tumours and support the potential for utilizing this ratio to predict intrinsic immune surveillance and sensitivity of breast tumours to specific immunotherapies. The gene discussed is STAT1; the disease is breast neoplasm.